Encapsulating contact allergens in liposomes, ethosomes, and polycaprolactone may affect their sensitizing properties

Cutaneous and Ocular Toxicology

Volumn 30, Issue 2, 2011, Pages 116-123

  Madsen, Jakob Torp ^a   Vogel, Stefan ^b   Johansen, Jeanne Duus ^c   Andersen, Klaus Ejner ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

allergen; Encapsulation; ethosomes; liposomes; local lymph node assay; polycaprolactone; sensitization

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ACETONE; CONTACT ALLERGEN; DICHROMATE POTASSIUM; ETHOSOME; ISOEUGENOL; LIPOSOME; OLIVE OIL; POLYCAPROLACTONE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DELIVERY SYSTEM; ENCAPSULATION; SENSITIZATION;

ALLERGENS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DINITROCHLOROBENZENE; EUGENOL; IMMUNIZATION; LIPOSOMES; LOCAL LYMPH NODE ASSAY; MICE; POLYESTERS;

EID: 79957507147     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2010.540765     Document Type: Article

References (32)

1. Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 2003, 258, 141-151. (Pubitemid 36712878)
2. Cosco D, Celia C, Cilurzo F, Trapasso E, Paolino D. Colloidal carriers for the enhanced delivery through the skin. Expert Opin Drug Deliv 2008, 5, 737-755.
3. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes- novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000, 65, 403-418. (Pubitemid 30122942)
4. Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly- epsiloncaprolactone microspheres and nanospheres: an overview. Int J Pharm 2004, 278, 1-23.
5. Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009, 366, 170-184.
6. de Leeuw J, de Vijlder HC, Bjerring P, Neumann HA. Liposomes in dermatology today. J Eur Acad Dermatol Venereol 2009, 23, 505-516.
7. Horwitz E, Pisanty S, Czerninski R, Helser M, Eliav E, Touitou E. A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999, 87, 700-705.
8. Jain S, Umamaheshwari R, Bhadra D, Jain N. Ethosomes: a novel vesicular carries for enhanced transdermal delivery of an anti HIV agent. Indian J Pharm Sci 2004, 66, 72-81.
9. Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 2000, 21, 1879-1885. (Pubitemid 30398506)
10. Godin B, Touitou E, Rubinstein E, Athamna A, Athamna M. A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: an in vivo study. J Antimicrob Chemother 2005, 55, 989-994. (Pubitemid 40883186)
11. Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A, Levi-Schaffer F. Intracellular delivery mediated by an ethosomal carrier. Biomaterials 2001, 22, 3053-3059. (Pubitemid 32768713)
12. Kaplun-Frischoff Y, Touitou E. Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids. J Pharm Sci 1997, 86, 1394-1399. (Pubitemid 28018321)
13. Godin B, Touitou E. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J Control Release 2004, 94, 365-379. (Pubitemid 38117147)
14. de Leeuw J, van der Beek N, Bjerring P, Neumann HA. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in combination with topical keratolytic agents. J Eur Acad Dermatol Venereol 2010, 24, 460-469.
15. Clemmensen A, Thormann J, Andersen KE. Allergic contact dermatitis from retinyl palmitate in polycaprolactone. Contact Derm 2007, 56, 288-289. (Pubitemid 46624109)
16. Marston S. Propyl gallate on liposomes. Contact Derm 1992, 27, 74-76.
17. Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H. Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res 2004, 21, 1818-1825. (Pubitemid 39390094)
18. Madsen JT, Vogel S, Karlberg AT, Simonsson C, Johansen JD, Andersen KE. Ethosome formulations of known contact allergens can increase their sensitizing capacity. Acta Derm Venereol 2010, 90, 374-378.
19. Madsen JT, Vogel S, Karlberg AT, Simonsson C, Johansen JD, Andersen KE. Ethosome formulation of contact allergens may enhance patch test reactions in patients. Contact Derm 2010, 63, 209-214.
20. Madsen JT, Andersen KE. Microvesicle formulations used in topical drugs and cosmetics affect product efficiency, performance and allergenicity. Dermatitis 2010, 21, 243-247.
21. Walde P, Ichikawa S. Enzymes inside lipid vesicles: preparation, reactivity and applications. Biomol Eng 2001, 18, 143-177. (Pubitemid 32893963)
22. Molpeceres J, Guzman M, Aberturas MR, Chacon M, Berges L. Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement. J Pharm Sci 1996, 85, 206-213. (Pubitemid 26055803)
23. Heeremans JL, Gerritsen HR, Meusen SP, Mijnheer FW, Gangaram Panday RS, Prevost R, Kluft C, Crommelin DJ. The preparation of tissue-type plasminogen activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage. J Drug Target 1995, 3, 301-310. (Pubitemid 26032032)
24. OECD. Organisation for Economic Co-operation and Development (OECD). Guideline for the Testing of Chemicals: (Part 429), 2002.
25. Andersen KE, Carlsen L, Egsgaard H, Larsen E. Contact sensitivity and bioavailability of chlorocresol. Contact Derm 1985, 13, 246-251. (Pubitemid 16217409)
26. McGarry HF. The murine local lymph node assay: regulatory and potency considerations under REACH. Toxicology 2007, 238, 71-89. (Pubitemid 47239226)
27. Jowsey IR, Clapp CJ, Safford B, Gibbons BT, Basketter DA. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay. Cutan Ocul Toxicol 2008, 27, 67-75. (Pubitemid 351883401)
28. Basketter DA, Gerberick GF, Kimber I. Skin sensitisation, vehicle effects and the local lymph node assay. Food Chem Toxicol 2001, 39, 621-627. (Pubitemid 32429476)
29. Jiménez MM, Pelletier J, Bobin MF, Martini MC. Influence of encapsulation on the in vitro percutaneous absorption of octyl methoxycinnamate. Int J Pharm 2004, 272, 45-55. (Pubitemid 38293010)
30. Wright ZM, Basketter PA, Blaikie L, Cooper KJ, Warbrick EV, Dearman RJ, Kimber I. Vehicle effects on skin sensitizing potency of four chemicals: assessment using the local lymph node assay. Int J Cosmet Sci 2001, 23, 75-83. (Pubitemid 32374831)
31. Ryan CA, Cruse LW, Skinner RA, Dearman RJ, Kimber I, Gerberick GF. Examination of a vehicle for use with water soluble materials in the murine local lymph node assay. Food Chem Toxicol 2002, 40, 1719-1725.
32. Bouwstra JA, Honeywell-Nguyen PL. Skin structure and mode of action of vesicles. Adv Drug Deliv Rev 2002, 54(Suppl. 1), S41-S55. (Pubitemid 35379954)